Latest filing published 04 Oct 2023 for Immunome Inc..
Insider track record
Franklyn G. Prendergast: trading record in brief
Franklyn G. Prendergast has filed trades across 3 companies (mainly through SEC (Form 4)), most often in ELI LILLY & Co, Vyant Bio, Inc. and Immunome Inc. Between 30 November 2006 and 2 October 2023, the trades on record add up to 17 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 4 October 2023: a share grant, in Immunome Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Franklyn G. Prendergast
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,840 shares0Common StockSEC:0001209191-23-052048:0
- 802 shares@ US$83.1827.5% of flowCommon StockSEC:0000059478-17-000217:0
- 2,500 shares0Common Stock, par value $0.0001 per shareSEC:0001349929-17-000083:0
- 2,500 shares0Common Stock, par value $0.0001 per shareSEC:0001349929-17-000043:0
- 2,088 shares@ US$76.6472.5% of flowCommon StockSEC:0000059478-16-000471:0
- 2,500 shares0Common Stock, par value $0.0001 per shareSEC:0001349929-16-000120:0
- 5,000 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-14-000293:0
7 of 7 declarations
